Press Releases

and/or
568 News Releases found
Crisis Vent
MSK Innovation: New Ventilator Designed to Provide Respiratory Support in Emergencies

A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory support equipment is unavailable.
Two-Piece Intubation Box
Announcement
MSK Innovation: Airway Procedure Redesign May Minimize Spread of COVID-19

Anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) have modified the protective boxes commonly employed during airway procedures in infectious patients, such as intubation, creating a two-piece setup instead of the usual single unit.
Sergio Giralt
Announcement
MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
The Tri-Institutional Therapeutics Discovery Institute logo
MSK Partnership News

Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that the Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) has renewed its collaborations with partners Takeda Pharmaceutical Company Limited (Takeda) and Bridge Medicines.
Atefeh Riazi Named as Chief Information Officer at Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has appointed Atefeh “Atti” Riazi as Chief Information Officer (CIO). In this role, Ms. Riazi will develop and implement an enterprise-wide, long-term strategic information technology (IT) plan and oversee the integration of data and technology resources across the organization.
Memorial Sloan Kettering Appoints Roxanne Taylor as Chief Marketing and Communication Officer

During 23 years with Accenture, Ms. Taylor helped transform the global technology and consulting firm into one of the world’s leading brands.
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
A New Era of Care: The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center to Open in January 2020

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.
Young Investigators Named Winners of 2019 Paul Marks Prize for Cancer Research

MSK award recognizes promising investigators for their efforts in advancing cancer research.
Neuro-Oncologist Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of Memorial Sloan Kettering Cancer Center

After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that Lisa M. DeAngelis has been named Physician-in-Chief and Chief Medical Officer. A leading expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.
Study on Sexual Harassment and Gender Disparities Among Gynecologic Oncologists Highlighted in ASCO’s 2019 Press Program

Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared new data from a survey of members of the Society of Gynecologic Oncology (SGO) showing that sexual harassment and observed gender discrimination continue to be significant issues in the medical community. The results of the study found that more than 60 percent of gynecologic oncologists had experienced sexual harassment, while only 10 percent of survey respondents reported the incident. The findings were presented as part of the press program for this year’s annual meeting of the American Society of Clinical Oncology (ASCO).